Increasing Viral Hepatitis Knowledge Among Urban Ethnic Minority Youth: Findings from a Community Based Prevention Intervention

  • Ijeoma OparaEmail author
  • David T. Lardier
  • Andriana Herrera
  • Pauline Garcia-Reid
  • Robert J. Reid
Original Paper


Viral hepatitis (VH) knowledge among youth is understudied in the United States. There has been a rise in VH cases in the U.S. in the wake of the opioid epidemic. Innovative approaches to preventing the infection are needed especially in urban communities. This study presents preliminary findings from a community-based HIV/AIDS, substance abuse, and VH prevention education intervention for ethnic minority youth in a northeastern urban community. We aimed to evaluate VH knowledge and factors associated with knowledge. Participants in the study completed a baseline survey followed by an exit survey measuring VH knowledge after the intervention. The survey was completed by 691 individuals. Logistic regression analyses were conducted and indicated that there was a significant increase (82.3%) in VH knowledge among youth who participated in the intervention. The development and implementation of VH knowledge interventions can be crucial in alleviating the rise of VH infections in the U.S.


Viral hepatitis knowledge Urban youth Community Education 



The first author was supported by a training grant from the National Institute on Drug Abuse (Grant No. 5T32 DA07233). The study was funded by the Center for Substance Abuse Prevention (Grant No. SP022-19-01).

Compliance with Ethical Standards

Conflict of interest

No potential conflict of interest was reported by the authors.


  1. 1.
    Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., et al. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574.CrossRefGoogle Scholar
  2. 2.
    Knick, T., Sherbuk, J. E., & Dillingham, R. (2019). Knowledge of hepatitis C risk factors is lower in high incidence regions. Journal of Community Health, 44(1), 12–15.CrossRefGoogle Scholar
  3. 3.
    Jablonka, A., Solbach, P., Wöbse, M., Manns, M. P., Schmidt, R. E., Wedemeyer, H., et al. (2017). Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015. European Journal of Gastroenterology and Hepatology, 29(8), 939–945.CrossRefGoogle Scholar
  4. 4.
    National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved from
  5. 5.
    Centers for Disease Control & Prevention [CDC]. Hepatitis A. Retrieved from
  6. 6.
    Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D. S., Van Damme, P., Abbas, Z., et al. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. The Lancet Gastroenterology & Hepatology, 3(6), 383–403.CrossRefGoogle Scholar
  7. 7.
    Ogholikhan, S., & Schwarz, K. B. (2016). Hepatitis vaccines. Vaccines, 4(1), 6.CrossRefGoogle Scholar
  8. 8.
    Nishimura, A., Shiono, P., Stier, D., Shallow, S., Sanchez, M., & Huang, S. (2012). Knowledge of hepatitis B risk factors and prevention practices among individuals chronically infected with hepatitis B in San Francisco, California. Journal of Community Health, 37(1), 153–158.CrossRefGoogle Scholar
  9. 9.
    Chang, E. T., Nguyen, B. H., & So, S. K. S. (2008). Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pacific Journal of Cancer Prevention, 9, 605–613.Google Scholar
  10. 10.
    Forde, K. A., Tanapanpanit, O., & Reddy, K. R. (2014). Hepatitis B and C in African Americans: Current status and continued challenges. Clinical gastroenterology and hepatology: The official clinical practice journal of the American Gastroenterological Association, 12(5), 738–748.CrossRefGoogle Scholar
  11. 11.
    National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved from
  12. 12.
    Centers for Disease Control and Prevention. (2016). Surveillance for viral hepatitis-United States, 2016. Retrieved from
  13. 13.
    Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., et al. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181.CrossRefGoogle Scholar
  14. 14.
    Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016). Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clinical Infectious Diseases, 62(10), 1287–1288.CrossRefGoogle Scholar
  15. 15.
    Liang, T. J., & Ward, J. W. (2018). Hepatitis C in injection-drug users—a hidden danger of the opioid epidemic. New England Journal of Medicine, 378(13), 1169–1171.CrossRefGoogle Scholar
  16. 16.
    Ward, J. W. (2016). The hidden epidemic of hepatitis C virus infection in the United States: Occult transmission and burden of disease. Topics in Antiviral Medicine, 21(1), 15–19.Google Scholar
  17. 17.
    Ly, K. N., Xing, J., Klevens, R. M., Jiles, R. B., Ward, J. W., & Holmberg, S. D. (2012). The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of Internal Medicine, 156(4), 271–278.CrossRefGoogle Scholar
  18. 18.
    Mentha, N., Clément, S., Negro, F., & Alfaiate, D. (2019). A review on hepatitis D: From virology to new therapies. Journal of Advanced Research. Scholar
  19. 19.
    Centers for Disease Control and Prevention. Retrieved from
  20. 20.
    Dalton, H. R., Saunders, M., & Woolson, K. L. (2015). Hepatitis E virus in developed countries: One of the most successful zoonotic viral diseases in human history? Journal of Virus Eradication, 1(1), 23–29.Google Scholar
  21. 21.
    Nyamathi, A., Kennedy, B., Branson, C., Salem, B., Khalilifard, F., Marfisee, M., et al. (2013). Impact of nursing intervention on improving HIV, hepatitis knowledge and mental health among homeless young adults. Community Mental Health Journal, 49(2), 178–184.CrossRefGoogle Scholar
  22. 22.
    Dombrowski, K., Sittner, K., Crawford, D., Welch-Lazoritz, M., Habecker, P., & Khan, B. (2016). Network approaches to substance use and HIV/Hepatitis C risk among homeless youth and adult women in the United States: A review. Health, 8(12), 1143.CrossRefGoogle Scholar
  23. 23.
    Quinn, K., Fong, C., Guarino, H., & Mateu-Gelabert, P. (2019). Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City. Drug and Alcohol Dependence, 194, 453–459.CrossRefGoogle Scholar
  24. 24.
    Prussing, C., Bornschlegel, K., & Balter, S. (2015). Hepatitis C surveillance among youth and young adults in New York City, 2009–2013. Journal of Urban Health, 92, 387–399.CrossRefGoogle Scholar
  25. 25.
    Guarino, H., Marsch, L. A., Deren, S., Straussner, S. L., & Teper, A. (2015). Opioid use trajectories, injection drug use, and hepatitis C virus risk among young adult immigrants from the former Soviet Union living in New York City. Journal of Addictive Diseases, 34, 162–177.CrossRefGoogle Scholar
  26. 26.
    Hadland, S. E., Wood, E., Nosova, E., Kerr, T., & DeBeck, K. (2017). Cessation of injecting and preceding drug use patterns among a prospective cohort of street-involved youth. Journal of Adolescent Health, 61(5), 612–618.CrossRefGoogle Scholar
  27. 27.
    Klevens, R. M., Jones, S. E., Ward, J. W., Holtzman, D., & Kann, L. (2016). Trends in injection drug use among high school students, US, 1995–2013. American Journal of Preventive Medicine, 50, 40–46.CrossRefGoogle Scholar
  28. 28.
    Lardier, D. T., Jr., Opara, I., Herrera, A., Henry, M., Garcia-Reid, P., & Reid, R. J. (2019). Sexual negotiation skills and risky behavior on sexual partnerships, HIV knowledge, and risk perception among urban youth of color: A latent class analysis. Journal of HIV/AIDS & Social Services. Scholar
  29. 29.
    Younossi, Z. M., Stepanova, M., Afendy, M., Lam, B. P., & Mishra, A. (2013). Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C. Journal of Viral Hepatitis, 20(8), 550–555.CrossRefGoogle Scholar
  30. 30.
    Murray, C. J. (2015). Shifting to sustainable development goals—Implications for global health. New England Journal of Medicine, 373(15), 1390–1393.CrossRefGoogle Scholar
  31. 31.
    Reid, R. J., Yu, D., & Garcia-Reid, P. (2014). Preventing substance abuse and HIV/AIDS among urban minority youth: Evidence from a university-community partnership. Journal of Addiction Research & Therapy, 5(3), 1–5.CrossRefGoogle Scholar
  32. 32.
    StataCorp. (2015). Stata base reference manual: Release 14. College Station, TX: StataPress.Google Scholar
  33. 33.
    Kim, M. J., Lee, H., Kiang, P., Watanabe, P., Torres, M. I., Halon, P., et al. (2015). Debunking the myth: Low knowledge levels of HBV infection among Asian American college students. Asia-Pacific Journal of Oncology Nursing, 2(1), 8–16.CrossRefGoogle Scholar
  34. 34.
    Lally, M. A., Montstream-Quas, S. A., Tanaka, S., Tedeschi, S. K., & Morrow, K. M. (2008). A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care and STDs, 22(1), 53–64.CrossRefGoogle Scholar
  35. 35.
    Liu, X., Shen, J., Kim, P., Park, S. M., Chun, S., Pan, J. J., et al. (2018). Hepatitis C infection screening and management in opioid use epidemics in the United States. The American Journal of Medicine, 131(11), 1276–1278.CrossRefGoogle Scholar
  36. 36.
    Jost, J. J., Tempalski, B., Vera, T., Akiyama, M. J., Mangalonzo, A. P., & Litwin, A. H. (2019). Gaps in HCV knowledge and risk behaviors among young suburban people who inject drugs. International Journal of Environmental Research and Public Health, 16(11), 1958.CrossRefGoogle Scholar
  37. 37.
    Chen, E. Y., North, C. S., Fatunde, O., Bernstein, I., Salari, S., Day, B., et al. (2013). Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults. Journal of Viral Hepatitis, 20(10), 708–714.CrossRefGoogle Scholar
  38. 38.
    Kwiatkowski, C. F., Fortuin Corsi, K., & Booth, R. E. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97(10), 1289–1294.CrossRefGoogle Scholar
  39. 39.
    Bryant, J. (2014). A study of young people who inject drugs: An opportunity to decrease high risk injecting by improving knowledge about hepatitis C prevention. Vulnerable Child and Youth Studies, 9(2), 104–113.CrossRefGoogle Scholar
  40. 40.
    Ma, G. X., Shive, S. E., Toubbeh, J. I., Tan, Y., & Wu, D. (2008). Knowledge, attitudes, and behaviors of Chinese hepatitis B screening and vaccination. American Journal of Health Behavior, 32(2), 178–187.CrossRefGoogle Scholar
  41. 41.
    Norton, B. L., Voils, C. I., Timberlake, S. H., Hecker, E. J., Goswami, N. D., Huffman, K. M., et al. (2014). Community-based HCV screening: Knowledge and attitudes in a high risk urban population. BMC Infectious Diseases, 14(1), 74.CrossRefGoogle Scholar
  42. 42.
    Centers for Disease Control and Prevention. Retrieved from
  43. 43.
    Knowles, V., Kaljee, L., Deveaux, L., Lunn, S., Rolle, G., & Stanton, B. (2012). National implementation of an evidence-based HIV prevention and reproductive health program for Bahamian youth. The International Electronic Journal of Health Education, 15(1), 173–190.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of Social WelfareStony Brook UniversityStony BrookUSA
  2. 2.Center for Interdisciplinary Research on AIDS, School of Public HealthYale UniversityNew HavenUSA
  3. 3.Department of Individual, Family, and Community StudiesUniversity of New MexicoAlbuquerqueUSA
  4. 4.Department of Psychiatry and Behavioral SciencesUniversity of New MexicoAlbuquerqueUSA
  5. 5.Department of Public HealthMontclair State UniversityMontclairUSA
  6. 6.Department of Family Science and Human DevelopmentMontclair State UniversityMontclairUSA

Personalised recommendations